EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Factors Associated with Severe Presentation and Mortality in ICU-Acquired Candidaemia: A 20-Year Single-Centre Retrospective Cohort

Ayse Sena Sisman iD, Ugur Onal iD, Busra Calisir iD, Emel Yilmaz, Esra Kazak iD, Yasemin Heper, Guven Ozkaya iD, Remzi Iscimen, Cuneyt Ozakin iD, Beyza Ener iD, Halis Akalin iD

Journal of Clinical Medicine · 04.11.2026 · 15 (21) · 8597

DOI: 10.3390/jcm15218597 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 04.11.2026. Verfasst von Ayse Sena Sisman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Türkiye. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The risk factors for the severe presentation (severe sepsis or septic shock) are not fully understood in ICU-acquired candidaemia. The primary objective of this study was to evaluate risk factors for the severe presentation (severe sepsis or septic shock) and mortality in patients with candidaemia in ICUs. Secondarily, we compared 28-day mortality between patients treated with fluconazole and those treated with an echinocandin.

Methods

A retrospective cohort design was employed in a single-center ICU setting, encompassing a study period from 2004 to 2023. Adult patients who had Candida growth in blood cultures taken 48 h after admission to the ICU were included in the study. Risk factors for the severe presentation (severe sepsis and septic shock) and mortality were evaluated in the 141 patients included in the study. The treatment comparison between fluconazole and echinocandins was performed in 113 patients (with 48-h rules) and 125 patients (without 48-h rules).

Results

Among 141 patients, 77 (54.6%) died within 28 days. We found that in the multivariable model, APACHE II score, TPN use, steroid use, and concomitant bacteremia were associated with severe presentation. Each one-point increase in APACHE II score was associated with higher risk of severe presentation (adjusted OR 1.146, 95% CI 1.056–1.242; p = 0.001). TPN use and steroid use were also associated with higher risk (adjusted OR 3.297, 95% CI 1.265–8.590; p = 0.015; and adjusted OR 6.067, 95% CI 1.486–24.768; p = 0.012, respectively). Concomitant bacteraemia was associated with lower odds of severe presentation. Patients with severe presentation (severe sepsis or septic shock) had a higher risk of 28-day mortality than patients with sepsis (adjusted OR 8.06, 95% CI 2.60–25.00; p < 0.001). In the primary cohort (n = 113; overlap weights), 28-day mortality was 49.2% with fluconazole and 52.1% with echinocandin (OR 1.12, 95% CI 0.37–3.45; p = 0.838). Results were consistent in the 125-patient cohort without the 48-h rule (OR 1.40, 95% CI 0.51–3.81; p = 0.508).

Conclusions

Each one-point increase in APACHE II score on admission, TPN use, and steroid use was associated with severe presentation in ICU-acquired candidaemia. The severity of the clinical presentation at the onset of candidaemia (presence of severe sepsis or septic shock) was strongly associated with 28-day mortality. No difference in 28-day mortality was detected between fluconazole and echinocandin treatment, but this comparison was imprecise and cannot inform antifungal choice.

Schlagwörter

Stichwörter der Autor:innen

antifungal treatmentcandidaemiaechinocandinsfluconazoleintensive care unitmortality

Autor:innen und Institutionen

  • Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Türkiye.
  • Department of Medical Microbiology, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Türkiye.
  • Department of Biostatistics, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Türkiye.
  • Department of Anesthesiology and Reanimation, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Türkiye.

ORCID-Profile: Ayse Sena Sisman, Ugur Onal, Busra Calisir, Esra Kazak, Guven Ozkaya, Cuneyt Ozakin, Beyza Ener, Halis Akalin

Zitieren

APA

Sisman, A. S., Onal, U., Calisir, B., Yilmaz, E., Kazak, E., Heper, Y., Ozkaya, G., Iscimen, R., Ozakin, C., Ener, B., & Akalin, H. (2026). Factors Associated with Severe Presentation and Mortality in ICU-Acquired Candidaemia: A 20-Year Single-Centre Retrospective Cohort. Journal of Clinical Medicine, 15(21), 8597. https://doi.org/10.3390/jcm15218597

Vancouver

Sisman AS, Onal U, Calisir B, Yilmaz E, Kazak E, Heper Y, et al. Factors Associated with Severe Presentation and Mortality in ICU-Acquired Candidaemia: A 20-Year Single-Centre Retrospective Cohort. Journal of Clinical Medicine. 2026;15(21):8597. doi:10.3390/jcm15218597

BibTeX
@article{Sisman2026,
  author = {Sisman, Ayse Sena and Onal, Ugur and Calisir, Busra and Yilmaz, Emel and Kazak, Esra and Heper, Yasemin and Ozkaya, Guven and Iscimen, Remzi and Ozakin, Cuneyt and Ener, Beyza and Akalin, Halis},
  title = {Factors Associated with Severe Presentation and Mortality in ICU-Acquired Candidaemia: A 20-Year Single-Centre Retrospective Cohort},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {21},
  pages = {8597},
  doi = {10.3390/jcm15218597}
}
Kostenlos starten →